Focused Shockwave Therapy vs. Physical Rehab for Knee Osteoarthritis
This study is comparing two treatments for knee osteoarthritis (OA), a condition causing joint pain and stiffness. It's testing Focused Shockwave Therapy against standard Physical Rehabilitation. You might be able to join if you have been diagnosed with Grade I, II, or III knee OA in one or both knees. The researchers want to see if one treatment is better at reducing your knee pain. We don't know yet if this study is actively looking for participants, but it plans to enroll 60 people.
- Study design
- This is a single-blind randomized study, meaning you won't know which treatment you're receiving, but the researchers will. It plans to include 60 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main goal is to measure changes in pain 8 to 12 weeks after treatment begins.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Clinical Outcomes of Focused Shockwave Therapy Without Adjunct Rehabilitation Compared to Standard Physical Rehabilitation in Patients With Grade I-III Knee Osteoarthritis: A Single-Blind Randomized Study
At a glance
Conditions
NCT07567365
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Westminster Spine & Injury Center
Westminster, Coloradostudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Cameron A Hall, DC, PhD · PRINCIPAL_INVESTIGATOR · Pulse Wave USA
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in WOMAC Pain Subscale score from baseline to the primary endpoint - likely 8 or 12 weeks after treatment begins.8 to 12 weeks
The primary outcome measure will be the between-group difference in change from baseline in WOMAC Pain Subscale score at 12 weeks.